• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Beyond the OCM: How Are Commercial Payers & Employers Delivering Value-Based Cancer Care? Part 3


Experts from The US Oncology Network discuss the future of value-based cancer care, and what practices can do as the Oncology Care Model expires.

In this webinar from The American Journal of Managed Care®'s Oncology Value Coalition, experts from The US Oncology Network discussed the future of value-based cancer care.

Despite many successes, the Oncology Care Model (OCM) is set to expire in July 2022, with no replacement on the horizon. That doesn't mean the lessons of the OCM will be forgotten, but continuing the quality care efforts will be difficult. How will practices continue team-based care, patient navigation, and other enhanced services?

The speakers were:

  • Rhonda Henschel, senior director of payer solutions, The US Oncology Network
  • Ben Jones, vice president of government relations and public policy
    McKesson Specialty Provider Organization, The US Oncology Network
  • Stuart Staggs, senior director of strategic programs, The US Oncology Network
  • Lalan Wilfong, MD,vice president of payer relations and practice transformation, The US Oncology Network

In segment 3, they discussed oncology drugs in value-based care.

Watch Segment 1.

Watch Segment 2.

Watch Segment 4.

Related Videos
Pat Van Burkleo
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Pat Van Burkleo
Ben Jones, McKesson/Us Oncology
Sandra Stein, MD
Pat Van Burkleo
Dr Denise Holston
Robert Groves, MD
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
Pat Van Burkleo
Related Content
© 2024 MJH Life Sciences
All rights reserved.